Merck's Keytruda stumbles again in stomach cancer, this time in new patients

26th April 2019 Uncategorised 0

Gastric cancer is a tough nut to crack, and Merck superstar Keytruda has stumbled in the disease area—again. New phase 3 study data show Keytruda-plus-chemo couldn’t outdo chemo alone at extending the lives of some previously untreated patients.

More: Merck's Keytruda stumbles again in stomach cancer, this time in new patients
Source: fierce